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A B S T R A C T
Background: Rheumatic fever (RF) classically occurs after group A Streptococcus (GAS) pharyngitis in
children aged over 5 years in developing countries. The present report describes the bacterial and host
determinants in non-related toddlers who developed RF diagnostic criteria after toxic shock syndrome
(TSS).
Methods and results: A 13-month-old boy and a 14-month-old girl presented GAS TSS. After several
weeks, multiple subcutaneous nodules as well as migratory polyarthritis or monoarthritis developed in
both children, fulﬁlling Jones criteria of RF. The relevance of the Jones criteria for very young children is,
however, debatable and their use might lead to the unnecessary prescribing of secondary prophylaxis. A
molecular analysis of both bacterial and host factors was carried out in an attempt to decipher the
combination that could have led to such uncommon, but very similar presentations. The twoGAS isolates
belonged to the usual, although distinct, invasive emm-types 1 and 3. Both isolates carried a wide set of
prophage-encoded virulence factors, with only the speG and speA superantigen-encoding genes in
common. Both patients shared the HLA DQB1*0301 allele, which has been associated with susceptibility
to GAS necrotizing fasciitis.
Conclusions: Our study exempliﬁes the particularity of RF in young children and the complex role of
superantigens and streptodornases in GAS-related pathologies.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Severe group A Streptococcus (GAS) diseases are responsible for
more than 500 000 deaths per year, essentially in developing
countries.1 The greatest burden is due to rheumatic fever (RF; 233
000 deaths) and invasive diseases (163 000 deaths), such as toxic
shock syndrome (TSS).1 Challenging questions remain regarding
the control of these two GAS-related pathologies as well their
pathogenesis.
RF represents a major problem in developing countries (which
account for 80% of the world’s population). Although epidemic
resurgences of RF have been observed in the USA,2 it has virtually
disappeared in wealthy industrialized countries with a prevalence* Corresponding author. Tel.: +32 2 650 97 75; fax: +32 2 650 97 70.
E-mail address: psmeeste@ulb.ac.be (P.R. Smeesters).
1 Laurence Van Melderen and Anne Vergison contributed equally to this work.
1201-9712/$36.00 – see front matter  2009 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.06.025of less that 0.1%. An unfortunate consequence of the decline in RF
in industrialized countries has been a parallel reduction in related
research and publications.3 Our understanding of RF pathogenesis
has somewhat improved, but the underlying factors andmolecular
mechanisms from both the bacterial and human sides are far from
being clearly identiﬁed.4 The diagnosis of RF still relies upon the
Jones criteria, which were ﬁrst described in 1944.5 Although
subsequently modiﬁed, revised and updated, the contemporary
criteria remain quite similar to the original ones. Criteriamight not
be fully appropriate to diagnose non-typical RF cases or to exclude
similar clinical entities. RF occurs classically after a GAS
pharyngitis in children aged 5–15 years,2 although less frequently,
cases fulﬁlling RF diagnostic criteria are also met in children under
5 years of age.2 At this age, less carditis and more arthritis are
observed than in the classical presentation.6,7
In terms of RF control and prevention, only secondary
prophylaxis of RF has been proved to be cost-effective and
practical in the poorest countries.3 To our knowledge, thisses. Published by Elsevier Ltd. All rights reserved.
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in children aged under 5 years.
TSS remains an uncommon GAS disease and has never been
described with subsequent RF.1 The incidence of invasive GAS
disease (10% of which are TSS) in developed countries is estimated
at 2.45/100 000 population per year.1 Recent data suggest that
invasive GAS infections occur at increased rates in developing
countries. In developing countries, GAS is the most common cause
of invasive bacterial disease in young infants aged 7–59 days.8
One of themajor GAS virulence factors is theM protein encoded
by the emm gene, which constitutes the basis for molecular typing
(emm-typing).4,9 Historically, RF has been associated with ‘rheu-
matogenic’ strains of GAS (such as emm-types 1, 3, 5, 6, 18, 19 or
24).4,10 emm-type 1, as well as emm-type 3, is also predominantly
associated with invasive infections.11,12 In addition to the emm
gene, GAS strains carry numerous other virulence factor genes,
most of them tending to be located on prophages. Prophage-
encoded virulence factors are of two classes: (1) the pyrogenic
toxin superantigens (PTSAgs or streptococcal pyrogenic exotoxins
(Spe)), which are potent immunostimulators capable of non-
speciﬁc T cell activation and (2) the non-PTSAgs, such as DNases
and phospholipase A2, involved in host–pathogen interactions.
13
Superantigens have been shown to contribute to the development
of TSS and probably to RF.14 The exact molecular mechanisms
allowing for speciﬁc GAS-associated pathologies are still not
understood.4,15
We describe here two cases of non-related toddlers presenting
RF diagnostic criteria following TSS. A comparison of GAS and host
(human leukocyte antigen; HLA) factors was undertaken in an
attempt to decipher the combination leading to such uncommon
but very similar pathologies. Special attention was given to
bacterial virulence factors usually associated with streptococcal
TSS and/or RF (emm-type and superantigens), as well as the
prophage content of the two GAS isolates.
2. Materials and methods
2.1. Case deﬁnition
The diagnoses of TSS and RF were based on the consensus
deﬁnition16 and updated Jones criteria,17 respectively. According
to the Jones criteria, RF is highly probable in the presence of two
major manifestations (carditis, polyarthritis, chorea, erythemaTable 1
Laboratory data at presentation and at follow-up.
Variable Presentation
Patient 1 Patie
Day 5 Day
Hemoglobin (g/dl) 8.5 7.6
Hematocrit (%) 26.7 24
Platelet count (109/l) [Au?2] 64 90
White blood cell count (109/l) [Au?2] 34.22 14.4
Neutrophils (%) 87 81
C-reactive protein (mg/dl) 47 29
Sedimentation rate (mm/h) 89
Partial thromboplastin time (INR) 1.33 1.66
Urea nitrogen (mg/dl) 114 120
Creatinine (mg/dl)a 0.9 1.21
pH 7.29 7.22
Total bilirubin (mg/dl)a 2.4 1.5
Aspartate aminotransferase (U/l) 106 72
Alanine aminotransferase (U/l) 195 22
Antistreptolysin O (U/ml) 86
Anti-Streptococcus desoxyribonuclease B (U/ml) <75
INR, international normalized ratio.
a To convert the values for creatinine to micromoles per liter, multiply by 88.4 andmarginatum, subcutaneous nodules) or of one major and two
minor manifestations (arthralgia, fever, elevated erythrocyte
sedimentation rate (ESR) or C-reactive protein (CRP), prolonged
PR interval), if supported by evidence of preceding group A
streptococcal infection.17
2.2. Host factors
HLA molecular typing was performed using PCR and a
sequence-speciﬁc oligonucleotide genotyping method (Immunol-
ogy Department, ULB–Hospital Erasme, Brussels, Belgium).18
2.3. Detection of bacterial virulence factors
emm-typing was performed as previously described.19 The
presence of 17 virulence genes, including 11 superantigens (speA,
speC, speG, speH, speI, speJ, speK/L, speL/M, speM, smeZ and ssa) and
six non-superantigens (spd1, spd3, spd4, sdn, sda and sla) was
tested by PCR. The latest classiﬁcation of superantigenswas used.14
Published primers20–22 or primers obtained by allelic sequence
multiple alignments were used (Supplementary information–
Table S1). PCR ampliﬁcations were further sequenced on both DNA
strands. To test whether the virulence genes mentioned above
were located on inducible bacteriophages, bacteriophage lysates
were obtained by mitomycin C treatment of the liquid cultures of
both isolates.13 Following a standard bacteriophage puriﬁcation
method, the lysates were observed by electron microscopy to
evaluate the presence and morphological characteristics of
bacteriophages.13
Bacteriophage DNA was puriﬁed as described by Vlaminckx
et al.23 The presence of virulence factor genes identiﬁed in isolates
1 and 2, was further tested on puriﬁed bacteriophage DNA using
the primers described above. Primers speciﬁc to chromosomally
encoded genes (speB, 16SRNA and parC) were used as negative
control in the PCR detection of bacteriophage-encoded genes.
3. Case reports
3.1. Patient 1
A 13-month-old boy presentedwith fever of 5-day duration and
arthritis of the left wrist. Upon admission, intravenous (IV)
amoxicillin–clavulanate (100 mg/kg/day tid) treatment wasFollow-up Normal pediatric range
nt 2 Patient 1 Patient 2
5 Day 28 Day 20
9.4 9.1 11–13
37.5 27 35
579 1113 260–480
7 10.85 14.58 6.00–16.00
49 51 40–70
3.8 5.8 <1
125 136 1–10
1.19 1.11 <1.31
16 15 10–40
0.2 0.3 0.23–0.56
7.35–7.45
0.2 0.2 0.6–1.4
31 54 10–40
40 21 5–30
474 <120
<75 600 <100
to convert total bilirubin to micromoles per liter, multiply by 17.1.
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sated shock andwas empirically treated with ceftriaxone (100 mg/
kg/day bid) and clindamycin (30 mg/kg/day qid), as well as
intensive care supportive therapy (hemodynamic support with
digoxin and dopamine). Despite this treatment, he evolved
towards a decompensated shockwith severe hypotension (systolic
arterial pressure of 55 mmHg), renal failure, coagulopathy,
thrombocytopenia, generalized erythematous macular rash, and
aseptic meningitis (Table 1), fulﬁlling the TSS case deﬁnition
criteria. Ceftriaxone was replaced with penicillin (500 000 IU/kg/
day in six doses), and IV immunoglobulin (2 g/kg) was added after
multi-susceptible GAS (penicillin, erythromycin, clindamycin,
ciproﬂoxacin, sulfamethoxazole/trimethoprim, and tetracycline)
was recovered from blood culture (isolate 1). His clinical course
was rapidly favorable; however 4 weeks after the onset (day 28),
he developed fever, increased CRP and ESR, arthralgia, migratory
polyarthritis (wrist and ankle), and subcutaneous nodules (in the
under-xiphoid region and the 7th right intercostal space). The
histopathology of these nodules was compatible with RF-
associated nodules (area of necrosis surrounded by connective
tissue inﬁltrated by lymphocytes). At this time, he presented an
elevated titer of antistreptolysin O and normal titer of anti-
Streptococcus desoxyribonuclease B (Table 1). Three months after
the onset, an increase in antistreptolysin O titer (day 120: 561 U/
ml) was evidenced. Cardiac echographywas normal. As the patient
met the Jones criteria with two major criteria (polyarthritis and
subcutaneous nodules) and two minor (fever and elevated CRP),
aspirin treatment (75 mg/kg/day) was started for RF, as well as
secondary antibiotic prophylaxis with intramuscular (IM) ben-
zathine benzylpenicillin (50 000 IU/kg/month). The fever ceased
24 h after the initiation of the aspirin treatment. IM penicillin was
shifted to daily oral syrup, as the smallmuscularmass of this young
child did not allow for repeated IM administration of benzathine.
His clinical evolution has been uneventful during 4 years of follow-
up.
3.2. Patient 2
A 14-month-old girl presented with symptoms of fever and
stomatitis for the last 3 days. A blood culture was drawn and a
conservative treatment prescribed. Two days later, she was called
back due to a multi-susceptible GAS positive blood culture (isolate
2). She was rapidly transferred to our hospital formanagement of a
compensated shock. Treatment with penicillin (500 000 IU/kg/day
in six doses), clindamycin (30 mg/kg/day qid), and IV immuno-
globulin (total administered dose 1.3 g/kg) was started immedi-
ately. A few hours later, she developed severe hypotension
(systolic arterial pressure of 60 mmHg), renal failure, lactic
acidosis, coagulopathy, thrombocytopenia, generalized convul-
sions, and aseptic meningitis (Table 1), fulﬁlling the TSS case
deﬁnition criteria. Intensive care supportive therapy included 4
days of ventilation associated with hemodynamic support
(dobutamine, dopamine and noradrenaline) and hemodialysis.
Her subsequent clinical evolution was favorable. On day 20, she
developed fever, elevated CRP and ESR, arthralgia and arthritis of
the right ﬁrst metatarsus joint, and subcutaneous nodules (on the
external surface of the left Achilles tendon and on the occipitus).
She had an elevated titer of anti-Streptococcus desoxyribonuclease
B (Table 1), but her cardiac echography was normal. Serological
control 3 months after onset showed a slow decrease in anti-
Streptococcus desoxyribonuclease B titer (day 120: 150 U/ml). As
she met the Jones criteria with one major criterion (subcutaneous
nodules on the external tendon surface) and three minor criteria
(arthralgia, fever, and elevated CRP), aspirin treatment (60 mg/kg/
day) and secondary antibiotic prophylaxis with IM benzathine
benzylpenicillin (50 000 IU/kg/month) was initiated, rapidlyswitched to oral daily syrup for the aforementioned reasons.
Her fever subsided after 24 h of aspirin treatment. Her clinical
evolution has been uneventful during 3 years of follow-up.
4. Results
The HLA molecular typing revealed that the two patients were
sharing the DQB1*0301 allele. Patient 1 showed a DQB1*0301/
DQB1*0603 and DRB1*13/DRB1*1303 haplotype and patient 2 a
DQB1*0301/DQB1*0501 and DRB1*08/DRB1*16 haplotype.
Patient 1 had an emm-type 1.0 (isolate 1) GAS infection,
whereas an emm-type 3.19 (isolate 2) was recovered from patient
2. Isolate 1 carried eight known virulence factor genes (ﬁve
superantigens: speA2, speC, speG, speJ, smeZ and three DNases: spd1
spd3, sda), while isolate 2 carried seven known virulence factor
genes (four superantigens: speA3, speG, speK/L, ssa, two DNases:
spd4, sdn, and one phospholipase: sla). The DNA sequence of these
virulence factor genes was 100% identical to those available in the
GenBank database. Isolates 1 and 2 only had the speG and speA
genes in common, although speA alleles were different. Some
virulence factors are quite similar at the protein level, hence
corresponding to biologically related functions and therefore
possibly playing a similar role in virulence. For instance, the SpeA2
superantigen present in isolate 1 shared 47% amino acid sequence
identity with the Ssa superantigen present in isolate 2 (data not
shown). Similarly, the streptodornase Sda (isolate 1) shared 49%
identity with the streptodornase Sdn (isolate 2) (data not shown).
Virulence factor genes are often carried by bacteriophages and
are therefore able to move from one strain to another through
horizontal gene transfer. PCR detection of the abovementioned
virulence genes was carried out on bacteriophage lysates obtained
from both isolates. Five of the eight virulence genes (speA2, speC,
spd1, spd3, sda) of isolate 1 and six of the seven genes (speA3, speK/
L, spd4, ssa, sla, sdn) of isolate 2 were indeed encoded by inducible
bacteriophages. The other virulence genes might be either
chromosomally encoded or carried by non-inducible bacterio-
phages or by bacteriophages that were not induced under our
experimental conditions. Bacteriophage lysates were observed by
electronmicroscopy. Fig. 1 shows that at least twomorphologically
distinct bacteriophages were present in both isolates. The
signiﬁcance of this observation remains unclear.
5. Discussion
We report here two ﬁrst descriptions of RF following TSS in
toddlers. Although the disease occurred in an industrialized
country (Belgium), the two patients were from families originating
from countries where RF is still endemic (Morocco and Congo,
respectively). The clinical picture presented here, as well as its
molecular counterparts, could probably therefore have been
observed in any part of the world and may be of interest to
clinicians and researchers in different epidemiological settings.
While TSS diagnosis appears indisputable, the diagnosis of RF is
debatable. Both patients fulﬁlled the updated Jones criteria.17
Patient 1 had two major criteria (polyarthritis and subcutaneous
nodules) and two minor (fever and elevated CRP). Patient 2
presented one major criterion (subcutaneous nodules) and three
minor criteria (arthralgia, fever and elevated CRP). Subcutaneous
nodules are often associated with carditis in typical RF patients.
However, RF clinical presentations appear different in children
aged less than 5 years. One study has reported more isolated
arthritis (41%) as compared to older children (20%).6 These atypical
presentations in young children, including our two cases, should
perhaps be classiﬁed into a broader ‘post-GAS immunologic
syndromes’ deﬁnition. Among the post-GAS immunologic dis-
orders, only carditis and chorea are indisputably RF, implying a
Figure 1. Morphological diversity in bacteriophages in group A Streptococcus isolates 1 and 2. Transmission electron microscopy after negative staining shows four
bacteriophages belonging to the Siphoviridae family. Bacteriophages from images A and B belong to isolate 1, while those from images C and Dwere carried by isolate 2. They
present icosahedral heads of variable size and morphology (B and C: 45 nm; A and D: 55 nm) and non-contractile tails of variable length (A: 230 nm; B: 240 nm; C and D:
180 nm) (magniﬁcation  160 000).
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based diagnosis such as in RF does not appear satisfactory in many
pediatric ‘atypical’ patients and yet it constitutes the best
classiﬁcation to guide rational clinical management. We followedthe criteria and decided to consider that our two children had
presented RF. We treated them accordingly, with a 5-year
secondary penicillin prophylaxis. However, ensuring that second-
ary prophylaxis is delivered to those who need it, is one of several
Table 2
Comparison of the virulence factor genes carried by invasive group A Streptococcus isolates.
Strains whose genome has been fully sequenced Prevalence of virulence factor among invasive infectionsb
(%)
Virulence
factors
Isolate 1
TSS/RF
Isolate 2
TSS/RF
SF370 Wound
infection
MGAS5005 Invasive
infection
SSI-1 and
MGAS315 TSS
Darenberg, Sweden
2007 (Ref. 24)
Vlaminckx, the
Netherlands
2003 (Ref. 21)
Bidet, France
2007 (Ref. 25)
emm1 emm1 emm1.6 emm1.0 12 25 25
emm3 emm3.19 emm3.1 <5 13 8
speA speA2 speA3 ND speA2 speA3 10 45 35
speC spec ND speC ND ND 61 42 43
speG speG speG speG speG speG 79 91a NT
speH ND ND speH ND ND 18 13 NT
speI ND ND speI ND ND NT NT NT
speJ speJ ND speJ speJ ND 19 48a NT
speK/L ND speK/L ND ND speK/L NT NT NT
smeZ smeZ ND smeZ smeZ ND 88 31 39
ssa ND ssa ND ND Ssa 17 29a 20
spd1 Spd1 ND spd1 ND ND NT NT NT
spd3 Spd3 ND spd3 spd3 ND NT NT NT
spd4 ND spd4 ND ND spd4 NT NT NT
sda Sda ND ND sda ND NT NT NT
sdn ND sdn ND ND Sdn NT NT NT
sla ND sla ND ND Sla NT NT NT
TSS, toxic shock syndrome; RF, rheumatic fever; ND, not detected; NT, the analysis was not performed in the study (not tested). In this table, the emm1 and emm3 genes are
considered as independent virulence factor genes. The speA, speC, speG, speJ, speK, smeZ, and ssa genes encode superantigens. The spd1, spd3, spd4, sda, and sdn genes encode
streptodornases. The sla gene encodes a phospholipase. The characteristics of emm-type 1 and 3 GAS strains whose genomes have been sequenced have been included. The
data of three representative epidemiological studies including more than 70 isolates for which at least six virulence factors have been tested are included. Note that invasive
disease strains comprise isolates that caused occult bacteremia, puerperal fever, necrotizing fasciitis, osteomyelitis, mastoiditis, TSS, etc. As they cannot strictly be compared
in terms of disease physiopathology and/or severity, this may complicate the analysis of possible associations between virulence factors and speciﬁc clinically deﬁned cases.
a Percentage calculated on a subset of the study only including the eight most prevalent emm-types.
b TSS accounts for around 10% of invasive disease.
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This is particularly true when limited healthcare funds are
available and in an era of attempts to rationalize antibiotic
prescribing.
Virulence refers to the degree of pathogenicity of a microbe.
The word ‘virulent’ derives from the Latin word ‘virulentus’,
meaning ‘full of poison’. The GAS isolates described in the present
report are most likely highly virulent from a classical micro-
biological standpoint, since a rather high number of known
virulence factor genes were detected in both strains (eight and
seven, respectively). Comparative genomic analyses of the 12
sequenced GAS strains was carried out and revealed that these
strains carry between three and eight virulence genes (average of
5.3 per strain) (data not shown). Table 2 shows that the virulence
factor genes carried by the two isolates were similar to those
encountered in the ‘usual’ invasive strains.12,21,24,25 However,
these virulence factor genes are also commonly found in GAS
isolated from benign infections and carriage.11,26,27 The pre-
valence of virulence factors in invasive diseases might reﬂect the
prevalence of these genes in the circulating GAS population.28 As
a consequence, this wide distribution of virulence factor genes
among strains from a broad spectrum of clinical sources does not
allow the establishment of a straight correlation between emm-
type, virulence factors and speciﬁc pathologies. The high number
of virulence factors found in most GAS, and particularly in
invasive disease-causing strains, could simply reﬂect the fact that
a threshold number of superantigen and DNase genes is
necessary, but not sufﬁcient to cause a severe pathology. The
exact nature of the superantigens and DNases themselves might
not be the crucial point, since these proteins share amino acid
homology and have redundant biological functions.14 Other
parameters might certainly inﬂuence the virulence of these
isolates, notably the regulation of virulence gene expression and,
potentially, the presence of not yet described virulence genes.
Nevertheless, some correlations between emm-types and pathol-
ogies can be drawn. emm-types 1 and 3 are signiﬁcantlyassociated with TSS, as is the speA superantigen.11 In acute RF,
the cross-reactive immune response to host cardiac tissue and the
reacting T-cells might be driven by superantigens.14 emm-type 3
is frequently recovered in RF and has been associated with the
presence of the speK/L superantigen gene.4,14 Moreover, a recent
study demonstrated that theM1 protein itself is a superantigen,29
hence possibly explaining the particular predominance of emm-
type 1 in TSS.
It is well known that antibiotic resistance genes are spreading
from strain to strain through horizontal gene transfer.30 The same
is true for virulence factors. For example, in industrialized
countries, the speA1 allele in emm-type 1 strains was replaced
by speA2 allele in strains isolated after 1988. Interestingly, a 36-kb
chromosomal region was also characteristic of post-1988 emm-
type 1 isolates,31 suggesting that horizontal transfer had occurred
and that these strains have been subsequently selected. Knowing
that an increase in invasive infections was noted in the 1980s,
multiple horizontal gene transfer eventsmight have contributed to
the emergence of successful GAS clones.31,32 The GASmajor class of
mobile genetic elements that carry virulence genes is represented
by bacteriophages.33 Bacteriophages are viruses that are speciﬁc to
bacteria. The bacteriophage DNA is generally inserted at speciﬁc
locations in the bacterial chromosome (prophages) and replicates
as part of the host chromosome (lysogeny). These prophages can
enter the lytic cycle spontaneously and/or in response to speciﬁc
environmental conditions (notably treatments that cause DNA
damage like ciproﬂoxacin, mitomycin C, etc.) and produce phage
particles. Themajority of the virulence factor genes present in both
isolates 1 and 2 were located on inducible prophages. Bacterioph-
age location is certainly advantageous for gene dissemination
through horizontal transfer. Moreover, the presence of virulence
genes on inducible prophages could increase the virulence in itself
by a rapid and massive toxin production at prophage induction.13
This phenomenon is not restricted to in vitro conditions, as
prophage induction has been shown to occur in vivo by contact
with pharyngeal cells.34
Table A1
Primers sequences.
Virulence gene Primer 1 Primer 2 Length of the ampliﬁed fragment (bp) References
speA 50AGCCAACTTCACAGATCTAGT 50TCTAACTTTATAGTCTAATTC 432 *
speC 50TGCTATTTCATGTATTCTCGT 50GTGCCAATTTCGATTCTGCCG 619 *
speG 50ATTTTGACAATTATCATATTAT 50AACTTCATAATGTTTACTATC 570 *
speH 50GTGAATGTCCAGGGAAAAGG 50GCATGCTATTAAAGTCTCCATTG 317 20
speI 50AATGAAGGTCCGCCATTTTC 50TCTCTCTGTCACCATGTCCTG 516 20
speJ 50ATCTTTCATGGGTACG 50TTTCATGTTTATTGCC 535 21
speK/L 50GTGTGTCTAATGCCACCGTCT 50GGAACATATATGCTCCTAGAT 564 20
speL/M 50CAGCACCTTCCTCTTTCTCG 50GGAAAAAGAGGGACGCAAG 459 20
speM 50GGATGAGTGAATAAATCGGTAAAC 50AGTCTGGGACGATGATAA 425 20
smeZ 50TGGGATCCTTAGAAGTAGATAATA 50AAGAATTCTTAGGAGTCAATTTC 617 22
ssa 50ATGAATAAAAGAATAAGA 50TAAGGTGAACCTCTATAG 772 *
spd1 50CCCTTCAGGATTGCTGTCAT 50ACTGTTGACGCAGCTAGGG 400 20
spd3 50CAAATTGACTGACGCTAATGG 50CCGCTTCTTCAAACTCTTCG 481 20
spd4 50TGGCATTGCTTCATAGTAAAGG 50ATCTACCTGAAGCTTTGTCGTG 494 20
sdn 50AACGTTCAACAGGCGCTTAC 50ACCCCATCGGAAGATAAAGC 489 20
sda 50AGCATAGCCCCAAAAATGTG 50TGCTACAGCATTGAAGACACG 379 20
sla 50CTCTAATAGCATCGGCTACGC 50AATGGAAAATGGCACTGAAAG 440 20
* indicates that the primer was obtained by allelic sequences multiple alignments (data not shown).
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host immunity data. HLA antigens participate in disease suscept-
ibility, as they play a crucial role in the activation of the immune
response. Kotb et al. proposed that the HLA class II allelic variation
contributes to differences in severity of invasive streptococcal
infections through their ability to regulate the cytokine response
triggered by streptococcal superantigens.35 The HLA DQB1*0301
allele present in both patients, has been shown to predispose to
necrotizing fasciitis (haplotype DRB1*11/DQB1*0301, non-signiﬁ-
cant trend). Moreover, SpeA, which was present in both isolates,
speciﬁcally binds to the HLA DQ molecule.36 As both patients
presented a common HLA DQ allele, this could also explain in part
their similar clinical presentation. Different and conﬂicting results
on the association between RF and HLA class II have been found in
different populations.2 There is no doubt that other host
immunogenetic factors, including variation in class II-linked genes
and cytokine genes, could also inﬂuence the outcome.37
The relevance of the Jones criteria for very young children is
debatable and their use might lead to the unnecessary prescribing
of secondary prophylaxis. These two case reports exemplify the
relativity of the commonly used word ‘virulence’. Virulence factors
are certainly necessary but not sufﬁcient to cause a speciﬁc
pathology. The clinical outcome of an infectious disease is
determined by multiple intricate interactions between the causal
microorganism, the host, and the environment. Although some
basic research on pathogenesis can take place in laboratories
anywhere in the world, multidisciplinary collaborative studies
including clinicians and researchers fromdifferent epidemiological
settings would be of value.
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